PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
28356937-4	2017	The results indicated that resveratrol treatment may suppress growth, induce apoptosis, and decrease AngII, AT1R, VEGF and COX-2 levels in renal carcinoma ACHN and A498 cells.	Resveratrol	27-38	angiotensinogen	Homo sapiens	101-106	
24965170-2	2014	In cultured human vascular smooth muscle cells (VSMCs), we found that the activation of AMP-activated protein kinase (AMPK) by RSV inhibited angiotensin II (AngII)-induced phosphorylation of myosin phosphatase-targeting subunit 1 (MYPT1) and myosin light chain (MLC).	Resveratrol	127-130	angiotensinogen	Homo sapiens	141-155	
24965170-2	2014	In cultured human vascular smooth muscle cells (VSMCs), we found that the activation of AMP-activated protein kinase (AMPK) by RSV inhibited angiotensin II (AngII)-induced phosphorylation of myosin phosphatase-targeting subunit 1 (MYPT1) and myosin light chain (MLC).	Resveratrol	127-130	angiotensinogen	Homo sapiens	157-162	
22561451-0	2012	Resveratrol attenuates angiotensin II-induced senescence of vascular smooth muscle cells.	Resveratrol	0-11	angiotensinogen	Homo sapiens	23-37	
17561496-6	2007	The effects of resveratrol on isolated tissues or organs are well-described including molecular mechanisms leading to decreased arterial damage, decreased activity of angiotensin-II, increased nitric oxide, and decreased platelet aggregation.	Resveratrol	15-26	angiotensinogen	Homo sapiens	167-181	
20429690-0	2010	Resveratrol induces mitochondrial biogenesis and ameliorates Ang II-induced cardiac remodeling in transgenic rats harboring human renin and angiotensinogen genes.	Resveratrol	0-11	angiotensinogen	Homo sapiens	140-155	
20089851-8	2010	Resveratrol"s enhancement of Mn-SOD levels depended on the level of nuclear SIRT1, and it suppressed the cell death induced by antimycin A or angiotensin II.	Resveratrol	0-11	angiotensinogen	Homo sapiens	142-156